Investing at the intersection of climate and health.
Investment Stage: Series A
Portfolio 2
| Date | Name | Website | Total Raised | Location |
| 19.12.2025 | Neurable | neurable.com | $43.1M | United Sta... |
| 24.07.2025 | Bitfount | bitfount.com | $13M | United Kin... |
Mentions in press and media 15
| Date | Title | Description |
| 18.03.2026 | Ternary Therapeutics: €4.1 Million Raised For AI-Driven Molecular Glue Drug Discovery Platform | Ternary Therapeutics, a London-based biotechnology company, has raised €4.1 million (£3.6 million) in a seed funding round to advance its artificial intelligence-powered platform for drug discovery. The round was led by daphni, with partici... |
| 16.03.2026 | Ternary Therapeutics targets “undruggable” proteins with AI-designed molecular glues, raising €4.1 million | London-based BioTech startup Ternary Therapeutics has raised €4.1 million (£3.6 million) in Seed funding to scale an AI platform designed to create a new class of medicines known as molecular glues. The round was led by European venture fir... |
| 25.12.2025 | Neurable Secures $35M to Drive Everyday Brain-Computer Interface Technology Mainstream | Neurable secured $35 million in Series A funding. This investment accelerates its mission to embed noninvasive brain-computer interface (BCI) technology into daily life. The Neurable AI platform translates brain signals for consumer devices... |
| 23.12.2025 | Neurable: $35 Million Series A Raised To Bring Everyday Brain Computer Interface Tech To Market | Neurable has raised $35 million in a Series A round to accelerate the commercialization of Neurable AI, its compact brain signal-processing technology aimed at embedding noninvasive brain-computer interface capabilities into consumer device... |
| 19.12.2025 | Neurable Raises $35M in Series A Funding | Neurable, a Boston, Massachusetts-based developer of noninvasive brain-computer interface (BCI) technology designed for everyday life, raised $35m in Series A funding. The round was led by Spectrum Moonshot Fund, with participation from exi... |
| 10.12.2025 | Metri Bio: $5 Million Pre-Seed Secured To Advance Next-Generation Endometriosis Therapeutics | Metri Bio, a Boston-based biotechnology company focused on endometrial disease therapeutics, has raised five million dollars in an oversubscribed pre-seed financing round. Pillar VC led the round with participation from Pace Ventures, Slocu... |
| 24.07.2025 | Bitfount Secures $8M to Revolutionize Clinical Research with Federated AI | Bitfount secured $8 million in Series A funding. This capital fuels its privacy-preserving federated AI platform. It revolutionizes clinical research collaboration. The technology eliminates raw data sharing. It brings algorithms directly t... |
| 24.07.2025 | Bitfount raises $8m in Series A funding round | LONDON, UK, July 23, 2025 – Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Parkwalk Ad... |
| 23.07.2025 | Bitfount raises $8M to unlock clinical research data with federated AI | London-based Bitfount, the federated AI platform transforming clinical research collaboration, has secured $8 million in Series A funding to scale its privacy-preserving network across healthcare systems globally. Bitfount removes the data-... |
| 23.10.2024 | Berlin-based Dunia.ai raises €10.6 million to accelerate clean energy innovations | Dunia, a pioneering force in AI-driven material discovery, today announced it has secured €10.6 million in funding co-led by Elaia and redalpine. Other backers include the EIC, Pace Ventures, Kindred Capital, Deep Science Ventures, and Angl... |
Show more